Drug Trial Radar · NCT06056947
Evaluation of Efficacy and Safety of Two New Formulations Compared to Gynomax® XL Ovule
Last checked: Nov 19, 2026Latest source record: Sep 28, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
577
Actual
Start
Jul 20, 2020
Primary completion
May 6, 2021
Study completion Aug 26, 2021
Sponsor
- Lead sponsor
- Ege UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Monitor CRO; Exeltis Turkey
- First posted
- Sep 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- Female only, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Efficacy and safety of two new formulations compared to Gynomax® XL ovule in the treatment of trichomonal vaginitis, bacterial vaginosis, candidal vulvovaginitis and mixed vaginal infections was evaluated in this randomized, three-arms, multicentral study.
Conditions
- Trichomonal Vaginitis
- Bacterial Vaginosis
- Candidal Vulvovaginitis
- Mixed Vaginal Infections
Interventions
EVEGYN ADrug
EVEGYN A: Fixed-dose combination of 600 mg fenticonazole nitrate + 1000 mg tinidazole + 100 mg lidocaine vaginal ovule Single dose, single administration (1x1)
EVEGYN BDrug
EVEGYN B: Fixed-dose combination of 600 mg fenticonazole nitrate + 2000 mg tinidazole + 100 mg lidocaine vaginal ovule Single dose, single administration (1x1)
Gynomax® XL Vaginal OvuleDrug
200 mg tioconazole + 300 mg tinidazole + 100 mg lidocaine single dose / day, during three consecutive days (1x1 / 3 days)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of patients who had complete response to treatment according to clinical findingsTime frame: 13 days (+/- 5 days) after treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Ege University Family Planning and Infertility Application and Research Center
Izmir, Turkey (Türkiye)
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.